ロード中...
Therapeutic targets in age-related macular disease
Age-related macular disease (AMD) accounts for more than 50% of blind registration in Western society. Patients with AMD are classified as having early disease, in which visual function is well preserved, or late disease, in which central vision is lost. Until recently, there was no therapy availabl...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2929720/ https://ncbi.nlm.nih.gov/pubmed/20811159 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI42437 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|